Literature DB >> 9360206

Extrahepatic portal vein obstruction in children: anthropometry, growth hormone, and insulin-like growth factor I.

R N Mehrotra1, V Bhatia, P Dabadghao, S K Yachha.   

Abstract

BACKGROUND: Extrahepatic portal vein obstruction has been shown to cause growth retardation in children, though literature is scant. No information is available regarding the cause of growth retardation in these patients.
METHODS: To document the presence of growth retardation in this disease, we studied growth and nutrition in 33 consecutive prepubertal patients. Anthropometry, fasting growth hormone, and insulin-like growth factor I levels were compared in 22 well-nourished patients from this group with 35 age-matched well-nourished controls.
RESULTS: Mean +/- SD height standard deviation score of well-nourished patients (-1.88 +/- 1.33) was significantly below that of the controls (-1.06 +/- 0.64, p < 0.01). Patients also had significantly lower midarm muscle circumference z scores (-2.65 +/- 1.09) than controls (-1.17 +/- 1.09, p < 0.0001), though triceps skinfold thickness z scores were comparable in the two groups (-1.06 +/- 0.68 vs -1.24 +/- 0.79, p = NS). Insulin-like growth factor I z scores were significantly lower in patients (-1.48 +/- 0.88) than in controls (-0.49 +/- 1.09, p < 0.001), whereas basal growth hormone was significantly higher in patients (4.60 +/- 3.70 mIU/L) compared with controls (2.66 +/- 0.82, p < 0.01).
CONCLUSION: Extrahepatic portal vein obstruction in children leads to growth retardation. Anthropometric and preliminary hormonal evaluation suggest resistance to the action of growth hormone as a possible mechanism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360206     DOI: 10.1097/00005176-199711000-00006

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  15 in total

1.  Brush border enzymes and absorptive capacity in extrahepatic portal venous obstruction in children.

Authors:  Gurbakhshish Singh Sidhu; B R Thapa; Pawan Rawal; K K Prasad; C K Nain; B Nagi; Kartar Singh
Journal:  Hepatol Int       Date:  2010-09-05       Impact factor: 6.047

Review 2.  Extrahepatic Portal Venous Obstruction: What Should be the Mainstay of Treatment?

Authors:  Richa Lal; Moinak Sen Sarma; Manish K Gupta
Journal:  Indian J Pediatr       Date:  2017-06-14       Impact factor: 1.967

Review 3.  Portal vein thrombosis.

Authors:  Yogesh K Chawla; Vijay Bodh
Journal:  J Clin Exp Hepatol       Date:  2015-01-06

Review 4.  Natural history of portal cavernoma cholangiopathy.

Authors:  Manoj Kumar; Vivek A Saraswat
Journal:  J Clin Exp Hepatol       Date:  2013-08-27

5.  Revisiting extra hepatic portal vein obstruction in children from the north Indian gangetic plain.

Authors:  Sundeep Goyal; V K Dixit; A K Jain; O P Mishra; S K Jena; Jayant Ghosh
Journal:  Indian J Pediatr       Date:  2013-10-10       Impact factor: 1.967

Review 6.  Noncirrhotic portal hypertension.

Authors:  Harshal Rajekar; Rakesh K Vasishta; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

Review 7.  Idiopathic portal hypertension and extrahepatic portal venous obstruction.

Authors:  Rajeev Khanna; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-02-20       Impact factor: 6.047

8.  Relation of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 levels to growth retardation in extrahepatic portal vein obstruction.

Authors:  Lalit Nihal; Mukta R Bapat; Pravin Rathi; Nalini S Shah; Anjana Karvat; Philip Abraham; Shobna J Bhatia
Journal:  Hepatol Int       Date:  2008-09-20       Impact factor: 6.047

Review 9.  Insight into congenital absence of the portal vein: is it rare?

Authors:  Guo-Hua Hu; Lai-Gen Shen; Jin Yang; Jin-Hua Mei; Yue-Feng Zhu
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

10.  Improved body mass index after mesenterico-portal bypass.

Authors:  Mark D Stringer
Journal:  Pediatr Surg Int       Date:  2007-04-11       Impact factor: 2.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.